C.K. Cooper Downgrades Nabi Biopharmaceuticals (NABI) to Hold
Tweet
Share
E-mailGet Alerts NABI Hot Sheet
Price: $1.80 --0%
Rating Summary:
1 Buy, 0 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 10 | Down: 6 | New: 33
Rating Summary:
1 Buy, 0 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 10 | Down: 6 | New: 33
Join SI Premium – FREE
C.K. Cooper downgraded Nabi Biopharmaceuticals (NASDAQ: NABI) from Buy to Hold.
For more ratings news on Nabi Biopharmaceuticals click here and for the rating history of Nabi Biopharmaceuticals click here.
Shares of Nabi Biopharmaceuticals closed at $5.63 yesterday.
For more ratings news on Nabi Biopharmaceuticals click here and for the rating history of Nabi Biopharmaceuticals click here.
Shares of Nabi Biopharmaceuticals closed at $5.63 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Piper Sandler Double Downgrades Myriad Genetics (MYGN) to Underweight, 'Major Strategic Action Likely Needed'
- Citi Downgrades LexinFintech Holdings (ADR) (LX) to Neutral
- Jefferies Downgrades Givaudan SA (GIVN:SW) (GVDNY) to Hold
Create E-mail Alert Related Categories
DowngradesRelated Entities
CK CooperSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
